Seshadri Neervannan, Chief Operating Officer, on September 04, 2026, sold 4,564 shares in Tarsus Pharmaceuticals (TARS) for $387,940. Following the Form 4 filing with the SEC, Neervannan has control over a total of 79,007 common shares of the company, with 78,532 shares held directly and 475 controlled indirectly.
SEC Filing: